MAMarcelo S. El Azzi

Marcelo S. El Azzi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marcelo S. El Azzi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of progesterone supplementation during the first follicular wave and delaying induced luteolysis with a single prostaglandin F2α on time of luteolysis and ovulation in Holstein heifers

    by Iago M.R. Leão, Everardo Anta-Galván, Marcelo S. El Azzi, Teresita Valdés-Arciniega, João Paulo N. Martins

    This study aimed to evaluate the effect of progesterone (P4) supplementation during the first follicular wave and delayed induced luteolysis with only one PGF2α (PGF) treatment on d 6 of the modified 5d-CoSynch protocol on ovarian dynamics, serum P4 concentrations, and estrus expression of Holstein heifers. Heifers were pre-synchronized with a PGF on experimental d -2 (pre-PGF) and treated with GnRH on d 0 to induce a first follicular wave of the estrous cycle. On d 0, heifers were randomly assigned (n = 34/treatment) to one of 3 treatments (G5PP-P4, G5PP and G6P). Heifers in the G5PP-P4 had an P4 intravaginal insert placed on d 0 that was removed on d 5. Heifers in G5PP and G5PP-P4 received 2 PGF on d 5 and d 6 (PGF-1 and PGF-2, respectively). Heifers in the G6P received only one PGF on d 6 (PGF-1). Only heifers that had luteolysis and ovulation between pre-PGF and 2 d after GnRH were considered in the first follicular wave and used in the study (G5PP-P4, n = 25; G5PP, n = 29; and G6P, n = 25). Ovarian ultrasound was performed on d -2, 0, 2, 3, at the time of PGF-1 (d 5 for G5PP-P4 and G5PP, and d 6 for G6P), 24h after PGF-1, and then every 12h until ovulation. Additionally, ovarian ultrasound was also performed on d 5 in heifers in the G6P group. Blood was collected on d -2, every day from GnRH until PGF-1, and every 12h after PGF-1 until ovulation or 144h after PGF-1. Heifers supplemented with P4 had greater serum P4 from d 1 to d 5 than heifers not supplemented. Heifers in G5PP-P4 had slower follicular growth and smaller dominant follicles (DF) at PGF-1, and G6P heifers had the largest DF at PGF-1. By 36 and 48 h after PGF-1, all heifers in G5PP-P4 and G5PP, respectively, had serum P4 ≤ 0.45 ng/mL, whereas only 80% of heifers in G6P reached this threshold by 48 h. Treatment did not affect the proportion of heifers with functional CL at PGF-1, expressing estrus, and ovulating after PGF-1. However, despite a shorter interval from PGF-1 to ovulation, the ovulatory follicle was older and larger in G6P heifers at PGF-1 compared with those in the other treatments. In summary, not supplementing P4 and administering only one PGF on d 6 of the first follicular wave of dairy heifers altered the ovulation time but resulted in a similar proportion of heifers with ovulation at the end of the protocol. However, our results suggest that a single PGF dose on d 6 after GnRH may not be as efficient in promoting luteolysis as 2 PGF administrations on d 5 and 6. The impact of adopting these changes on fertility in a timed-AI protocol for dairy heifers such as a 5d-CoSynch still requires further investigation.


  • Open Access

    Effect of gonadorelin dose and an additional gonadorelin treatment 2 days after the initiation of Resynch-25 on ovarian dynamics and fertility of lactating Holstein cows

    by Iago M.R. Leão, Carlos E.C. Consentini, Marcelo S. El Azzi, Everaldo Anta-Galván, Teresita Valdés-Arciniega, Lucas Oliveira e Silva, Roberto Sartori, João Paulo N. Martins

    Our objective was to improve ovulatory response at the initiation of the Resynch-25 protocol by (1) increasing the dose of GnRH from 100 µg to 200 µg; and (2) giving a second GnRH treatment 56 h after the initiation of the protocol. We considered the experimental d 0 the day of the previous service. The experiment consisted of a 2 × 2 factorial design to compare the main effects of GnRH dose (100 vs. 200 µg) and GnRH treatment times (once vs. twice 56 h apart). A total of 2,111 previous services in 1,438 Holstein lactating cows were used. On d25, cows were assigned to receive either 100 or 200 µg of GnRH only on d25 or on d25 and 56 h later (d27). On d 32, cows diagnosed as nonpregnant (n = 1,076 services) were classified as with or without a corpus luteum (CL). Nonpregnant cows with a CL continued the Resynch-25 protocol receiving PGF2α treatments on d 32 and 33, followed by a GnRH 32 h later and timed AI 16 h after the last GnRH. Blood samples were collected in a subset of cows on d 25, 32, and 34 to assess serum P4 concentrations. In the same subset of cows, transrectal ultrasonographic examinations were performed on d 25, 29, 34 and 36 to assess ovarian parameters and ovulatory response to the GnRH treatments. The overall ovulatory response at the initiation of the protocol, defined as the ovulation between d 25 and 29, was not affected by days of GnRH treatment and averaged 41.9%. On the other hand, nonpregnant cows treated with the higher GnRH dose had a greater ovulatory response at the initiation of the protocol compared with cows treated with the lower dose (48.0% vs. 36.1%). Despite the increase in ovulatory response at the initiation of the protocol, the GnRH dose did not affect fertility of cows submitted to Resynch-25. Furthermore, the second GnRH treatment on d27 tended to decrease pregnancy per AI on d32 after AI (39.0% vs. 43.9%), but no effect of days of GnRH treatment was observed in the subsequent pregnancy diagnosis. The absence of a functional CL on d25 and ovulation at the initiation of the protocol were positively associated with improved fertility. However, the improvement in fertility of cows ovulating at the initiation of the protocol occurred only in cows with a functional CL on d25. In summary, despite increasing ovulatory response at the initiation of the protocol, the higher dose did not improve fertility. The extra GnRH on d27 did not increase ovulatory response at the initiation of the protocol and tended to decrease P/AI 32 d after AI of the Resynch-25. Also, no additive effect of the higher dose and extra GnRH treatment was observed. Despite the lack of overall treatment effect, data presented in this study suggests that the identification of CL functionality on d25 may help to optimize the resynchronization strategy used at nonpregnancy diagnosis to potentially increase fertility of cows reinseminated.

  • Open Access

    Multiple ovulation was positively associated with milk yield independently of circulating progesterone concentrations in multiparous high-producing Holstein cows submitted to Double-Ovsynch

    by T.J. Valdés-Arciniega, E. Anta-Galván, I.M.R. Leão, T.O. Cunha, M.S. El Azzi, N.B. Cook, J.P.N. Martins

    The present study aimed to determine the relationship between circulating progesterone (P4) concentrations and milk yield during the ovulatory follicular wave on the proportion of multiple ovulation (MOV) in multiparous high-producing Holstein cows (n = 1,345). The study used first-service multiparous cows submitted to a Double-Ovsynch program (GnRH; 7 d later, PGF2α; 3 d later, GnRH; 7 d later, GnRH [G1]; 7 d later, PGF2α [PG1]; 1 d later, PGF2α; ∼32 h later, GnRH [G2]; ∼16 h later, timed AI [TAI]). To assess ovulatory response and proportion of MOV, ovarian ultrasonography examinations were performed at G1 (n = 1,215) and G2 (n = 1,345) and from 40 to 48 h after each GnRH. Average milk yield (kg/d) for the weeks before G1 and PG1 were recorded. Blood samples were collected at G1 (n = 1,242) and PG1 (n = 1,333) to measure serum P4 concentrations. Milk yield for the 2 weeks before PG1 was 56.0 ± 0.2 kg/d. Overall, ovulation to G1 was 71.5%, and MOV to G1 was 16.6%. Circulating P4 concentration at G1 was higher in cows with single ovulation (SOV) at G1 than in cows with MOV (4.31 ± 0.08 vs. 3.70 ± 0.20 ng/mL, respectively). Overall, ovulation to G2 was 90.2%, and MOV to G2 was 13.7%. Cows with MOV to G2 also had lower P4 concentration at PG1 than cows with SOV (7.24 ± 0.28 vs. 8.91 ± 0.11 ng/mL, respectively). The interaction of serum P4 tertiles at PG1 × milk yield tertiles was not significant for MOV to G2. Nevertheless, independent of each other, MOV to G2 was positively associated with milk yield and negatively associated with serum P4 at PG1. The proportion of cows with MOV to G2 was greater for cows with previous MOV to G1 (32.9%) than for cows with SOV to G1 (9.8%). In summary, MOV in multiparous high-producing Holstein cows was highly associated with serum P4 concentrations, milk yield, and previous MOV. In addition, an increased proportion of MOV was associated with high milk yield tertile (≥58.5 kg/d) regardless of the serum P4 concentrations during the growth of the ovulatory follicle.


  • Open Access

    Effect of 200 µg of gonadorelin at the first gonadotropin-releasing hormone of the Resynch-25 on ovarian dynamics and fertility in lactating Holstein cows

    by Iago M.R. Leão, Marcelo S. El Azzi, Everaldo Anta-Galván, Teresita Valdés-Arciniega, João Paulo N. Martins

    Our objective was to determine the effect of a 200-µg dose of GnRH 25 d after previous artificial insemination (AI) in a Resynch-25 resynchronization program on ovulatory response, circulating progesterone (P4) concentrations before and after treatment, and pregnancy per AI (P/AI) compared with a 100-µg dose in lactating Holstein cows. Experimental d 0 was considered the day of the previous AI. Lactating dairy cows (n = 3,240) with an average of 126 d in milk (DIM) and between 1 and 6 services were randomly assigned to receive 100 µg or 200 µg of GnRH on d 25 (GnRH25). On d 32 after AI, cows diagnosed nonpregnant with the presence of a corpus luteum (CL) detected by ultrasound (n = 1,249) received PGF2α treatments on d 32 and 33, followed by a GnRH 32 h later and AI 16 h after this last GnRH. Blood samples were collected on d 25, 32, and 34 to evaluate serum P4 concentrations. Transrectal ultrasonographic examination was performed on d 25 and 27 to assess ovulatory response to GnRH25. Cows were checked for pregnancy on d 32, 46, and 88 after AI. The larger dose of GnRH increased the overall proportion of cows that ovulated to the GnRH25 (25.0% for the 100-µg dose vs. 32.5% for the 200-µg dose). However, when cows were evaluated separately according to the pregnancy status on d 32 after AI, we found no treatment effect within cows pregnant and nonpregnant. Even though treatment increased the proportion of cows with serum P4 ≤0.42 ng/mL at the last GnRH treatment (G2; 86.2% for the 100-µg dose vs. 93.0% for the 200-µg dose), it did not affect P/AI on d 32, 46, and 88. Furthermore, a greater proportion of cows without a functional CL at GnRH25 had circulating P4 concentrations ≥1.00 ng/mL on d 32 and lower than 0.42 ng/mL on G2. These cows also had a greater P/AI on d 32, 46, and 88. In summary, the larger dose of GnRH on d 25 after AI did not increase the ovulatory response in nonpregnant cows and P/AI on d 32, 46, and 88 after AI after the Resynch-25 program. Additionally, nonpregnant cows without a functional CL at GnRH25 were better synchronized after the Resynch-25 protocol and had greater P/AI on d 32, 46, and 88 after timed-AI.


  • Open Access

    Effect of using 200 μg of gonadorelin at the first gonadotropin-releasing hormone of the breeding-Ovsynch on ovulatory response and pregnancies per artificial insemination in first-service lactating Holstein cows

    by T.J. Valdés-Arciniega, I.M.R. Leão, E. Anta-Galván, T.O. Cunha, M.S. El Azzi, N.B. Cook, J.P.N. Martins

    This study aimed to determine if 200 μg of GnRH (gonadorelin hydrochloride) would increase ovulatory response and pregnancies per AI (P/AI) compared with 100 μg at the first GnRH of the breeding-Ovsynch of a Double-Ovsynch program (DO) in lactating Holstein cows. Weekly cohorts of primiparous (n = 719) and multiparous (n = 1,191) cows submitted to DO [GnRH - 7 d - PGF2α - 3 d - GnRH - 7 d - GnRH (G1) - 7 d - PGF2α (PG1) - 1 d - PGF2α - ~32 h - GnRH (G2) - ~16 h - TAI] for first timed-artificial insemination (TAI), randomly received either 100 μg or 200 μg of GnRH (gonadorelin hydrochloride) at G1 (primiparous, 64-75 DIM; multiparous, 59-70 DIM). Ovulation was determined by ultrasound 2 d after G1 (n = 1,294) and 2 d after G2 (n = 1,020). Blood samples were collected at G1 and at PG1 d to evaluate serum progesterone (P4) concentrations. Conventional (n = 314, Angus; n = 1,084, Holstein) and Holstein sexed-semen (n = 276) were used. Pregnancy was diagnosed on d 32, 46, 88, and 200 post-TAI. The high dose of GnRH (200 μg) increased overall ovulatory response to G1 compared with 100 μg (81.3% vs. 65.1%), being similar between parities (primiparous, 72.2%; multiparous, 73.9%). Mean serum P4 concentrations at PG1 did not differ between treatments (100 µg: 9.59 ± 0.15 ng/mL vs. 200 µg: 9.43 ± 0.15 ng/mL). Cows with no ovulation to G1 had higher serum P4 concentrations at G1 than cows with ovulation to G1 (6.27 ± 0.19 ng/mL vs. 4.66 ± 0.07 ng/mL). At PG1, the proportion of cows with functional CL (98.7% vs. 89.7%) and serum P4 concentrations (9.68 ± 0.12 ng/mL vs. 9.14 ± 0.22 ng/mL) were greater in cows that ovulated to G1 compared with cows that did not ovulate. Also, cows that ovulated to G1 had a greater increase in serum P4 concentrations from G1 to PG1 than cows with no ovulation (5.26 ± 0.12 ng/mL vs. 3.32 ± 0.25 ng/mL). The high dose of GnRH improved overall P/AI at 32 d post-TAI in cows inseminated with conventional semen (54.6% vs. 48.2%) and tended to improve P/AI on 46 (48.8% vs. 44.9%), 88 (47.6% vs. 43.4%) and 200 (45.3% vs. 41.2%) d post-TAI. Primiparous cows inseminated with conventional semen had better P/AI than multiparous cows at d 32 (58.2% vs. 49.4%), 46 (55.1% vs. 44.4%), 88 (53.2% vs. 43.2%) and 200 (51.6% vs. 40.7%) post-TAI. Primiparous cows treated with 200 µg GnRH had lower P/AI on d 32, 46, 88, and 200 post-TAI when inseminated with sexed semen than with conventional semen. In summary, the higher dose of GnRH at G1 improved ovulatory response and P/AI at d 32 post-TAI and tended to improve P/AI at d 46, 88, and 200 post-TAI in cows inseminated with conventional semen. Moreover, the effect of treatment on P/AI in primiparous cows depended on semen type (conventional vs. sexed semen).


  • Open Access

    Effect of inducing accessory corpus luteum formation with gonadotropin-releasing hormone or human chorionic gonadotropin on the day of embryo transfer on fertility of recipient dairy heifers and lactating cows

    by Marcelo S. El Azzi, João Luiz Cardoso, Raul A. Landeo, José Henrique F. Pontes, José C. de Souza, João Paulo N. Martins

    The objective was to determine the effect of inducing an accessory corpus luteum (CL) using GnRH or human chorionic gonadotropin (hCG) on the day of in vitro-produced (IVP) embryo transfer (ET) on pregnancy per ET (P/ET) and calving/ET in dairy heifers and lactating cows. Dairy heifers (11-15 mo of age; n = 1,547) and lactating cows (n = 1,480) detected in estrus by tail chalk (d 0) were used as recipients. Before ET, the presence of a CL was evaluated by transrectal palpation from d 6 to 9 of the estrous cycle. Animals with a CL were randomly assigned to receive 1 of 3 treatments immediately before ET: control (no treatment; n = 1,009), GnRH (86 µg of GnRH; n = 1,085) and hCG (2,500 IU; n = 1,069). Embryos were implanted in the uterine horn ipsilateral to the ovary with a CL (fresh IVP embryos, n = 2,544; vitrified IVP embryos n = 545; slow-freezing IVP embryos, n = 74). Pregnancy diagnosis was performed on d 37 ± 3 of gestation by transrectal palpation. Pregnancy loss data and calving records were collected from the dairy farm management software. Treatment did not affect P/ET, calving/ET, or pregnancy loss either overall or within parity. When treatments inducing CL formation were combined (GnRH + hCG), heifers tended to have greater P/ET than controls (67.7 vs. 63.5%, respectively). Yet, calving/ET were similar. Response variables were also analyzed within embryo type and parity. For heifers receiving stage 6 (blastocyst) fresh IVP embryos, hCG had greater P/ET than controls (74.5 vs. 51.1%, respectively). In addition, GnRH tended to have greater P/ET than controls (67.8 vs. 51.2%, respectively). However, calving/ET in heifers receiving blastocyst fresh IVP embryos was similar among treatments. When only stage 7 (expanded blastocyst) fresh IVP embryos were considered, primiparous GnRH cows had greater P/ET (59.3 vs. 47.1%) and calving/ET (48.6 vs. 38.1%) than hCG. Moreover, hCG showed decreased calving/ET compared with controls in primiparous cows transferred with expanded blastocyst fresh IVP embryos. In summary, the effects of hCG or GnRH at ET on P/ET and calving/ET were inconsistent according to different embryo characteristics (e.g., embryo stage) and parity of recipients. Furthermore, treatment did not improve the overall fertility outcomes for recipient animals receiving IVP embryos.


  • Open Access

    Effects of human chorionic gonadotropin on the last day of a 5-day CIDR Synch protocol and 5 days later on circulating progesterone concentrations and luteal area in Holstein heifers

    by Marcelo S. El Azzi, Teresita Valdes-Arciniega, Everardo Anta-Galvan, Iago M.R. Leão, Rodrigo V. Sala, Meliton Fosado, José C. de Souza, João Paulo N. Martins

    Summary: Our objective was to determine the effect of replacing gonadotropin-releasing hormone (GnRH) with human chorionic gonadotropin (hCG) on the last day of a 5-day controlled internal drug release (CIDR) Synch (day 0) and inducing corpus luteum (CL) formation with hCG on day 5 on serum progesterone (P4) concentration and luteal dynamics in dairy heifers. Heifers receiving hCG on day 0 had a larger luteal area and greater serum P4 concentration on day 5 than heifers receiving GnRH on day 0. Heifers that received hCG on day 0 and 5 had greater serum P4 concentrations on day 7 than the heifers in the other treatments. In addition, hCG on day 5 promoted a greater proportion of heifers with ≥2 CL on day 12 and a larger luteal area of the original CL, which resulted in a larger total luteal area on day 12.


  • Replacing the first gonadotropin-releasing hormone treatment in an Ovsynch protocol with human chorionic gonadotropin decreased pregnancies per artificial insemination in lactating dairy cows

    by E.M. Cabrera, M.R. Lauber, T. Valdes-Arciniega, M.S. El Azzi, J.P.N. Martins, T.R. Bilby, P.M. Fricke

    Our objective was to compare the effect of treatment with GnRH at the first treatment (G1) of the Breeding-Ovsynch portion of a Double-Ovsynch (DO) protocol with human chorionic gonadotropin (hCG) on pregnancies per artificial insemination (P/AI) in lactating dairy cows. In experiment 1, lactating dairy cows (n = 1,932) submitted to a DO protocol for first timed artificial insemination (TAI) on 2 commercial dairy farms were blocked by parity (primiparous vs. multiparous) and were randomly assigned to receive 100 µg of GnRH versus 2,500 IU of hCG at G1. Overall, P/AI 39 d after TAI for cows inseminated with sexed dairy semen was greater for cows treated with GnRH than for cows treated with hCG within each parity (primiparous: 42.6% vs. 38.2%; multiparous: 39.4% vs. 30.3%). Similarly, P/AI 39 d after TAI for multiparous cows inseminated with conventional beef semen tended to be greater for cows treated with GnRH than for cows treated with hCG (41.1% vs. 34.3%). In experiment 2, lactating Holstein cows (n = 43) were blocked by parity and were randomly assigned to the treatment protocols described for experiment 1. Ovaries were evaluated with transrectal ultrasonography immediately before treatment and 24, 28, 32, 36, and 40 h after treatment to assess time from treatment to ovulation, and blood samples were collected immediately before G1, at the first PGF2α treatment, 8 and 16 h later, at the second PGF2α treatment, 8 and 16 h later, at the second GnRH (G2) treatment, and at TAI to compare luteolysis based on serum progesterone (P4) concentrations. Although mean (± standard error of the mean) time from treatment to ovulation was approximately 2 h greater for cows treated with hCG than for cows treated with GnRH (33.7 ± 0.6 vs. 31.5 ± 0.6 h), P4 concentrations during luteolysis and the proportion of cows with complete luteolysis (P4 <0.4 ng/mL at G2) did not differ between treatments. We conclude that replacing 100 µg of GnRH with 2,500 IU of hCG at G1 of a DO protocol decreased fertility to TAI in lactating dairy cows but did not affect the rate or completeness of luteolysis despite the increased interval from treatment to ovulation.


  • Open Access

    Fatty acid profiles of the plasma and follicular fluid mares fed a combination of linseed and salmon oil

    by Jesús A.S. Viafara, Ricardo V. Portilho, Renata Maculan, José F. DE Souza Júnior, Camilla M. Silva, Paula G. Rodrigues, Marcelo S. EL Azzi, José C. DE Souza

    This study evaluated the presence of polyunsaturated fatty acids in circulating blood and in the ovarian follicular fluid of mares, after supplementation of the diet with linseed oil. Six Mangalarga Marchador mares, weighing 397.00±31.89 kg, were kept on native pasture, and assigned to the current study. In a switch over design, mares were randomly allocated to receive 150 ml of vegetable oil daily, containing polyunsaturated fatty acids n3 (62.23 g ALA, 20.34 g LA, 2.27 g EPA, 2.32 g DHA), (n=3) or no supplementation (n=3) in two replicates. Blood and follicular fluid samples were taken on the first day (D0) and every 30 days until the end of the supplementation period (D60). After 60 days of supplementation, mares were switched across the treatments. Plasma concentrations of linolenic acid in total fatty acids were higher (P=0.006) in the supplemented compared to the control group (1.89±0.13 vs. 1.49±0.13%). There were positive correlations between plasma linoleic acid and follicular fluid arachidonic acid (P=0.0106; r2=0.13) and between plasma alpha linolenic acid and follicular fluid EPA (P=0.0004; r2=0.2544). Data indicated a low to moderate relationship between the dietary linseed-based oil supplementation studied and circulating and follicular fluid polyunsaturated fatty acids contents in mares.